Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Jacques Quilici"'
Autor:
Stephan Grimaldi, Emilie Doche, Caroline Rey, Nadia Laksiri, Salah Boussen, Jacques Quilici, Emmanuelle Robinet, Fabien Devemy, Jean Pelletier
Publikováno v:
Case Reports in Neurology, Vol 9, Iss 2, Pp 173-178 (2017)
Introduction: An association of posterior reversible encephalopathy syndrome (PRES) and takotsubo is rare. We present the first case of a male patient. Case Report: A 69-year-old man presented to the hospital in a persistent comatose state following
Externí odkaz:
https://doaj.org/article/af2cd3f2a0ef438d83f77262502bcb86
Autor:
Jean Louis Bonnet, Pierre Deharo, Thomas W Johnson, Pierre Suchon, C. Bassez, L. Fourcade, Marianne Fernandez, Jacques Quilici, Marie-Christine Alessi, Guillaume Bonnet, Valentine Verdier, Pierre-Emmanuel Morange, Laurence Camoin-Jau, Thomas Cuisset, Manal Ibrahim
Publikováno v:
JACC: Cardiovascular Interventions. 10:2560-2570
Objectives: This study sought to evaluate the impact of initial platelet reactivity on the benefit of switched strategy. Background: TOPIC (Timing Of Platelet Inhibition after acute Coronary Syndrome) study suggested that switched dual antiplatelet t
Publikováno v:
JACC. Cardiovascular interventions. 11(5)
Autor:
Jean Ruf, Thomas Cuisset, Julien Fromonot, Jacques Quilici, Emmanuel Fenouillet, Laurie Bruzzese, Stefano Bonatti, Giovanna Mottola, Régis Guieu, Pierre Deharo
Publikováno v:
Canadian Journal of Physiology and Pharmacology
Canadian Journal of Physiology and Pharmacology, NRC Research Press, 2017, pp.272-7
Canadian Journal of Physiology and Pharmacology, 2017, pp.272-7
Canadian Journal of Physiology and Pharmacology, NRC Research Press, 2017, pp.272-7
Canadian Journal of Physiology and Pharmacology, 2017, pp.272-7
The role of hyperhomocysteinemia in coronary artery disease (CAD) patients remains unclear. The present study evaluated the relationship between homocysteine (HCys), adenosine plasma concentration (APC), plasma uric acid, and CAD severity evaluated u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08bb4cc5ccc0c6b91e86c11fa53e6d3c
https://hal.archives-ouvertes.fr/hal-01478198
https://hal.archives-ouvertes.fr/hal-01478198
Publikováno v:
The Annals of Thoracic Surgery. 98:1823-1826
We report the case of a 78-year-old woman with severe aortic valve stenosis that was successfully treated with transcatheter aortic valve implantation, with initial good hemodynamic results and clinical improvement of the patient. After 3 weeks, her
Autor:
P. Héno, J.-M. Gil, N.-C. Roche, U. Vinsonneau, Laurent Fourcade, Jacques Quilici, S. Kerebel, P. Paule, Y. Chabrillat, C. Jego
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 63:331-338
Resume But de l’etude Le diagnostic de myocardite aigue est difficile surtout quand la presentation clinique mime un syndrome coronaire aigu. Cette affection pourrait favoriser l’evolution vers une cardiomyopathie dilatee et la survenue d’aryth
Autor:
Marie Loosveld, Jacques Quilici, Jean-Louis Bonnet, Guillaume Bonnet, Valerie Verdier, Thomas Cuisset, Mathieu Pankert, Pierre Deharo, Pierre Morange, Marie-Christine Alessi, Marc Lambert
Publikováno v:
IJC Heart & Vessels. 4:188-192
BackgroundWe retrospectively studied the impact of the introduction of new P2Y12 inhibitors (prasugrel, ticagrelor) on platelet reactivity and clinical outcomes after Acute Coronary Syndrome (ACS) from a large single center registry.MethodsConsecutiv
Autor:
Jacques Quilici, Jean-Louis Bonnet, Pierre Deharo, Mathieu Pankert, Thomas Cuisset, Guillaume Bonnet, V. Verdier, Pierre Morange, Marie-Christine Alessi, Charlotte Grosdidier
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 63:222-227
Statin therapy is a cornerstone therapy for secondary prevention after acute coronary syndrome (ACS). However, the use of these drugs can be limited by side effects, mainly muscular pain. Ezetimibe is a newer lipid-lowering agent, with fewer side eff
Autor:
Jean Louis Bonnet, Charlotte Grosdidier, Pierre Deharo, Marie-Christine Alessi, Thomas Cuisset, Pierre-Emmanuel Morange, Guillaume Bonnet, Jacques Quilici
Publikováno v:
Platelets
Platelets, Taylor & Francis, 2016, 27 (8), pp.791-795
Platelets, Taylor & Francis, 2016, 27 (8), pp.791-795
International audience; Delay from the last intake of drug could be an important and unexplored variable in the biological response to antiplatelet agents after acute coronary syndrome (ACS) discharge. The objective was to define the impact of the de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0d83b9bef933649cf014cbf5222efe
https://hal.archives-ouvertes.fr/hal-01478123
https://hal.archives-ouvertes.fr/hal-01478123
Publikováno v:
JACC: Cardiovascular Interventions. 11:508-509
We have read with great interest the letter from Dr. Lozano and colleagues about our paper assessing the impact of on-treatment platelet reactivity on switching strategy after acute coronary syndrome (ACS) [(1)][1]. First, we would like to thank the